NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares (“ADS”) of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO) between June 5, 2023, and December 26, 2025, inclusive. You are hereby notified that the class action lawsuit Megan Dodge v. Mereo BioPharma Group plc, et al. (Case No. 1:26-cv-00988) has been commenced in the United States District ...